There appears to be a growing uproar in both the lay press and professional literature about the high cost of many pharmaceuticals. Is such an uproar justified?
July 2015 Digestive Health
Advertisement
Advertisement
Trending on Pharmacy Times
1
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
2
IRAKLIA Trial Shows Body Weight Doesn’t Alter Outcomes With On-Body Injector Isatuximab
3
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
4
Advancing Precision Oncology: Perspectives for Pharmacists on MRD Testing and Diagnostic Innovation
5
